Raising awareness of RSV vaccine options, midazolam and Wegovy strengths

PDL has some advice on RSV vaccination, and the strengths of midazolam and Wegovy This Practice Alert highlights some recent practice issues reported to PDL Professional Officers. Respiratory Syncytial Virus (RSV) vaccines Currently, two Respiratory Syncytial Virus (RSV) vaccines, Arexvy® and Abrysvo®, have been approved by the Therapeutic Goods Administration (TGA) for protecting adults against